Global Hypodermic Needle Market Size, Share, Opportunities, And Trends By Type (Safety Hypodermic Needle, Non-Safety Hypodermic Needle), By Application (Vaccination, Drug Delivery, Body Fluid Sample Collection), By End-User (Hospitals And Clinics, Ambulatory Care Centres), And By Geography - Forecasts From 2024 To 2029

The global hypodermic needle market is expected to grow at a compound annual growth rate of 6.42% over the forecast period to reach a market size of US$4,690.217 million in 2029, from US$3,034.881 million in 2022.

A hypodermic needle is a medical instrument utilized for infusing substances or extricating liquids from the body, ordinarily through subcutaneous, intramuscular, or intravenous courses. It comprises a hollow, round, and empty tube with a sharp tip and plunger, permitting the exact organization of drugs, immunizations, or withdrawal of blood or other liquids.

The worldwide hypodermic needle advertise includes the manufacturing, distribution, and selling of hypodermic needles utilized within the healthcare industry. Key viewpoints of the market include safety needles, non-safety needles, applications, end-users, geographical nearness, administrative environment, unused improvements, industry key players, and open well-being activities. Safety needles focus on aspects like healthcare employee safety, lessening the hazard of needlestick wounds.

Non-safety needles are conventional needles without extra security components. The worldwide hypodermic needle market is energetic and affected by components such as innovative headways, healthcare approaches, and the predominance of maladies that require the utilize of hypodermic needles in restorative medical intercessions.

Market Drivers:

• The increasing prevalence of diabetes is anticipated to boost the hypodermic needle market growth.

The market is predicted to experience a boost in the years ahead due to the increase in the prevalence rate of diabetes around the world. According to the information provided by the International Diabetes Federation, around 537 million adult individuals have been living with diabetes for years, between the ages of 20 and 79 category in the year 2021. Further, it has also been estimated that the global population living with diabetes is expected to grow to 643 million by 2030 and around 783 million by 2045.

Increasing global expenditure on diabetes has been expected to surge the adoption of advanced drug delivery solutions. Various companies and corporations have been offering advanced and novel solutions for diabetic patients, such as the easy delivery of drugs by needles in a patient's body.

• An increase in competitive analysis due to various corporation presence would bolster the hypodermic needle market.

Several firms and corporations have been making a considerable impact in the market in the past few years. The increasing expenditure on research and development was expected to surge in the next few years as corporations tend to increase their competitive advantage and overall market share globally. Iscon Surgicals Ltd., one of the key players in the market, has been providing and selling disposable hypodermic needles to its customers.

The company stated that its needle had been produced through high and advanced precision grinding, siliconization, and ultrasonic cleaning. The company's products are ISO Certified. Other corporations have been offering advanced hypodermic needles for their customers.

For instance, NIPRO, one of the largest needle manufacturers, produces around 11 billion units annually. The company stated that its products are not manufactured as PVC or latex. It also offers hypodermic needles in different lengths and sizes. These developments and trends are expected to play a significant role in the market during the forecast period.

• The rising rate of asthma and chronic disease is expected to propel the hypodermic needle market.

Hypodermic needle utilization is anticipated to surge within the projected period due to the expanding rate of asthma, around the world. According to the information given by the World Wellbeing Organisation (WHO), asthma is additionally included in the WHO Worldwide Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) and the United Nations 2030 Plan for Sustainable Development.  

The WHO has also been undertaking a few measures to upgrade the drug conveyance segment in lower and middle-income nations. With expanding industrialization, there has been a concern around high contamination, which has been one of the major components of the expanding prevalence rate of asthmatic patients. Subsequently, it is anticipated to improve the adoption of hypodermic needles and other drug-delivery products within the projected time period.

The industry is anticipated to surge due to the rise in the predominance rate of chronic infections around the world. This increment is anticipated to boost the adoption of needles and syringes that seem to securely deliver drugs into the body system. Moreover, increasing vaccination rates were also expected to enhance the demand for novel injectable solutions, worldwide. 

• Various favorable government regulations would increase the hypodermic needle market growth.

Various patients living with diabetes and asthma condition have been utilizing hypodermic needles on their own. These patients needed to desensitize drugs and infusions in case of distinctive unfavourably susceptible reactions. Governments around the world have been facilitating the directions and laws that permit patients to carry hypodermic needles without any major confinements. For example,  in March 2021, the Maryland Senate in the United States reported the passing of a novel bill decriminalizing the dispersion and ownership of hypodermic needles.

In addition, in October 2021, the New York Government reported the passing of a bill decriminalizing the distribution and sales of hypodermic needles within the state. Beneath this novel bill, hypodermic needles would not be considered as medicate gear. The government stated that the novel bill had been introduced to enhance the accessibility of the drug delivery systems to the people.

Company Product:

• B Braun™ Hypodermic Needles- B Braun™ Hypodermic Needles are designed for patient comfort with a smooth surface, light silicone coating, automated grinding and polishing process, low-friction lubrication, transparent hub design, color-coded hubs conforming to ISO 6009, and wide range of diameters and lengths.
• Safetouch Hypodermic Needles- Nipro's Safetouch hypodermic needles are a user-friendly, high-quality product with a transparent safety device that locks the needle inside the cover, reducing the risk of needlestick injuries for both patients and healthcare professionals.
• Monoject™ Hypodermic Safety Needles- The Monoject™ Hypodermic Safety Needle from Cardinal Health Inc. is a user-friendly, one-handed device that provides protection with just a thumb, enhancing clinician comfort and confidence. It features double-lock hinged arm technology, ensuring safety during use and after disposal. The device also features a reversible Audible and tactile click for safety activation. It is sterile, single-use, and individually packaged, making it a convenient and safe option for clinicians.

Key Developments:

• May 2023- High-performance abrasives are crucial for the manufacturing of hypodermic needles, ensuring smooth surfaces and precise beveling angles. Norton Abrasives offers tools for cutting, grinding, and polishing, delivering exceptional results and improving process efficiency and patient comfort.
• January 2023- MTD Group received FDA clearance for its DropSafeTM SicuraTM passive safety needle for intramuscular and subcutaneous injection of vaccines and drugs. The needle is designed to eliminate needlestick injuries and provide a fully safe injection experience. The needle is protected by a transparent shield that automatically locks after injection, requiring no incremental activation step by healthcare professionals. The device fulfils an unmet need for increased safety in the US and is CE certification pending.

Hypodermic Needle Market Scope:

 

Report Metric	Details
Market Size Value in 2022	US$3,034.881 million
Market Size Value in 2029	US$4,690.217 million
Growth Rate	CAGR of 6.42% from 2022 to 2029
Study Period	2019 to 2029
Historical Data	2019 to 2022
Base Year	2023
Forecast Period	2024 – 2029
Forecast Unit (Value)	USD Million
Segments Covered	Type Application End Users Geography
Companies Covered	B. Braun Melsungen AG NIPRO Cardinal Health Inc. Terumo Medical Corporation Smith’s Group Plc
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Customization Scope	Free report customization with purchase

 

Segmentation:

Global Hypodermic Needle Market is segmented and analyzed as below:

• By Type
  • Safety Hypodermic Needle
  • Non-Safety Hypodermic Needle
• By Application
  • Vaccination
  • Drug delivery
  • Body Fluid Sample Collection
• By End Users
  • Hospitals and Clinics
  • Ambulatory Care Centers
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Taiwan
    • Indonesia
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL HYPODERMIC NEEDLE MARKET BY TYPE

5.1. Introduction

5.2. Safety Hypodermic Needle

5.2.1. Market Opportunities and Trends

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Non-Safety Hypodermic Needle

5.3.1. Market Opportunities and Trends

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

6. GLOBAL HYPODERMIC NEEDLE MARKET BY APPLICATION

6.1. Introduction

6.2. Vaccination

6.2.1. Market Opportunities and Trends

6.2.2. Growth Prospects

6.2.3. Geographic Lucrativeness

6.3. Drug delivery

6.3.1. Market Opportunities and Trends

6.3.2. Growth Prospects

6.3.3. Geographic Lucrativeness

6.4. Body Fluid Sample Collection

6.4.1. Market Opportunities and Trends

6.4.2. Growth Prospects

6.4.3. Geographic Lucrativeness

7. GLOBAL HYPODERMIC NEEDLE MARKET BY END USERS

7.1. Introduction

7.2. Hospitals and Clinics

7.2.1. Market Opportunities and Trends

7.2.2. Growth Prospects

7.2.3. Geographic Lucrativeness

7.3. Ambulatory Care Centers

7.3.1. Market Opportunities and Trends

7.3.2. Growth Prospects

7.3.3. Geographic Lucrativeness

8. GLOBAL HYPODERMIC NEEDLE MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Type

8.2.2. By Application

8.2.3. By End Users

8.2.4. By Country

8.2.4.1. USA

8.2.4.1.1. Market Opportunities and Trends

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Opportunities and Trends

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Opportunities and Trends

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Type

8.3.2. By Application

8.3.3. By End Users

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Opportunities and Trends

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Opportunities and Trends

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Opportunities and Trends

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Type

8.4.2. By Application

8.4.3. By End Users

8.4.4. By Country

8.4.4.1. UK

8.4.4.1.1. Market Opportunities and Trends

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Opportunities and Trends

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Opportunities and Trends

8.4.4.3.2. Growth Prospects

8.4.4.4. Italy

8.4.4.4.1. Market Opportunities and Trends

8.4.4.4.2. Growth Prospects

8.4.4.5. Others

8.4.4.5.1. Market Opportunities and Trends

8.4.4.5.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Type

8.5.2. By Application

8.5.3. By End Users

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Opportunities and Trends

8.5.4.1.2. Growth Prospects

8.5.4.2. South Africa

8.5.4.2.1. Market Opportunities and Trends

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Opportunities and Trends

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Type

8.6.2. By Application

8.6.3. By End Users

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Opportunities and Trends

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Opportunities and Trends

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Opportunities and Trends

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Opportunities and Trends

8.6.4.4.2. Growth Prospects

8.6.4.5. Thailand

8.6.4.5.1. Market Opportunities and Trends

8.6.4.5.2. Growth Prospects

8.6.4.6. Taiwan

8.6.4.6.1. Market Opportunities and Trends

8.6.4.6.2. Growth Prospects

8.6.4.7. Indonesia

8.6.4.7.1. Market Opportunities and Trends

8.6.4.7.2. Growth Prospects

8.6.4.8. Others

8.6.4.8.1. Market Opportunities and Trends

8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. B. Braun Melsungen AG

10.2. NIPRO

10.3. Cardinal Health Inc.

10.4. Terumo Medical Corporation

10.5. Smith’s Group Plc

10.6. BD

10.7. Iscon Surgicals Ltd.

10.8. Narang Medical Ltd.

10.9. Medline Industries Inc.

10.10. Dynarex Corporation

B. Braun Melsungen AG

NIPRO

Cardinal Health Inc.

Terumo Medical Corporation

Smith’s Group Plc

BD

Iscon Surgicals Ltd.

Narang Medical Ltd.

Medline Industries Inc.

Dynarex Corporation